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1. Abstract 
 
 
There is a worldwide interest to reconstruct functional articular cartilage tissue that 
has been lost due to injury or disease. Lesions in the articular cartilage are frequent 
as each year millions of people suffer from joint injuries, which cost billions of dollars 
for economy and society. Although mistaken as a disease impairing only elderly 
persons, often young people are affected, who are considered too young to undergo 
artificial joint replacement surgery. Articular cartilage has a very limited capacity of 
self-regeneration following trauma, injury, overuse or disease, which is due to its 
avascular nature and the limited mobility of the chondrocytes inside the compact 
cartilaginous matrix. A loss of cartilaginous tissue after joint damage therefore is 
irreversible.  
Current treatment is limited to fighting the symptoms, such as pain and inflammation. 
Therefore many different scaffold constructs for articular cartilage repair have been 
thoroughly investigated over the past two decades. Various three-dimensional (3D) 
scaffolds have been evaluated, including alginate, hyaluronan, polyactic and 
polyglycolic acid, polyethylene glycol (PEG), agarose, fibrin and collagen, which aim 
to simulate and provide a cartilage-like environment to support proper chondrocyte 
growth and function.  (for review see Hunziker et al., 2002) [1] 
The aim of this study was to better understand chondrocyte interactions with their 
pericellular matrix, therefore we incorporated chondrocytes isolated from bovine 
condylar cartilage in 3D PEG hydrogels with different densities, some containing 
RGD or collagen type I. To examine cell response, we performed Live/Dead assay, 
histological and gene expression analysis for collagen type I and II, Sox9 and 
aggrecan. Chondrocyte viability was maintained within the hydrogels over a culture 
period of five weeks.  
This study demonstrates that constructs with a density from 1.5% to 3.5% showed an 
increase in matrix production (ECM) and cell proliferation, whereas on the other 
hand, hydrogels containing RGD or collagen type I, had no positive effect on EMC 
production or cell proliferation.  
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2. Introduction 
 
Cartilage is a highly specialized connective tissue consisting of round chondrocytes 
that organize the collagens, proteoglycans, sulfated glycosaminoglycans (sGAG, 
keratin sulfate and chondroitin sulfate) and non-collagenous proteins into an 
organized extracellular matrix (ECM) (Buckwalter and Mankin, 1998). [2]  
To be able to work with cartilage, it is essential to understand the process of 
chondrogenesis and endochondral ossification. Natural chondrogenesis begins with 
the condensation and proliferation of mesenchymal cells (MC), at different time points 
during embryonic development. During mesenchymal condensation, the cells 
aggregate and begin to produce collagen I, fibronectin and proteoglycans. [3] 
The aggregated cells then immediately begin to differentiate into chondroblasts.  
Condensed mesenchymal cells start expressing Sox9, a transcription factor that itself 
controls downstream genes such as Sox5, Sox6 and collagen II α1, promoting 
progenitor cells to secrete cartilage-specific ECM molecules. [4, 5]  
The three main types of cartilage, hyaline cartilage, elastic cartilage and 
fibrocartilage, vary in the composition of different types of collagen, fibrils and elastic 
fibers. (Young et al. 2000; Kirkham and Samarasinghe, 2009) While the predominant 
collagen in fibrocartilage is type I collagen, the predominant collagen in articular, 
hyaline cartilage is type II collagen. The collagenous framework is responsible for the 
form and the necessary firmness of the cartilage tissue. About 90% of the collagen in 
articular cartilage is type II collagen, which consists of three identical alpha-1 (II) 
chains, which are arranged in a triple helix. In 1971, the group around Hjertquist and 
Lamperg [6] showed in in-vivo studies on adult animals that cartilage defects heal 
with the formation of fibrocartilaginous repair tissue. It was shown that this repair 
tissue contains relatively low amounts of type II collagen and aggrecan which are 
functionally important markers of the chondrocyte phenotype (Benya and Shaffer, 
1982) [7] and a relatively high amount of type I collagen, which can’t be found in 
measurable amounts in normal healthy adult articular cartilage. With regards to the 
attempts of different tissue engineering methods to regenerate hyaline cartilage, it’s 
essential to differ between hyaline like tissue and other connective tissues referred as 
“hyaline like cartilage” and “fibrocartilage” in the literature. The limited reparative 
capacity and poor healing of hyaline cartilage is due to its particular structure [8] 
  5 
 
The most common proteoglycan found in cartilage is aggrecan, consisting of 
glycosaminoglycans, chondroitin sulfate, keratin sulfate and other sulfated 
polysaccharide chains. These side chains allow aggrecan to bind large amounts of 
water, which makes it resistible to compression during loading. In adult human and 
bovine cartilage 50-80% of GAGs are chondroitin sulfate (CS) chains. Several 
studies have shown that GAGs in adult human and bovine cartilage differ in their 
chain length, composition and sulfation as a function of development, age and 
disease. (Buckwalter et al., 1994; Lauder et al., 1998; Bayliss et al., 1999; Bayliss et 
al., 2000; Plaas et al., 2001; Sharma et al., 2007) It has been shown that the addition 
of HA to hydrogels or to a cell medium significantly increases cell proliferation and 
enhances the production of GAGs and collagen II. [9-12] 
By applying mechanical forces to cartilage, a pressure gradient is generated in the 
interstitial fluid, causing fluid flow, referred to as the hydraulic permeability. Because 
of the limited pore size and the interaction between the negatively charged GAGs 
and the water molecules, a flow resistance is formed, limiting the fluid flow thought 
the ECM. [13] 
During loading, synovial liquid is pressed into the synovial cavity of the joint, where 
the absorption of nutrients and the exchange of O2 and CO2 takes place. Thus, 
loading is essential for the nutrition and therefore for the function of cartilage. Another 
important glycoprotein is chondronectin, which mediates the attachment of 
chondrocytes to type II collagen. (Junqueira et al., 1996) [14] 
At the edge of hyaline cartilage, in the perichondral zone, chondrocytes are more of 
an ellipsoidal shape, whereas chondrocytes from the inner zone of the cartilage are 
round and exist in groups of up to eight cells. (Junqueira et al., 1996) [14] Fully 
differentiated chondrocytes synthesize type II collagen, proteoglycans, hyaluronic 
acid and chondronectin. The differentiation phase of chondrocytes is accompanied by 
a change in cell morphology and the expression of specific markers. Each stage 
expresses different collagens, like type II, VI, IX, X and XI collagen. Type VI collagen 
is a marker protein for early proliferative stages of chondrocyte differentiation, 
whereas type X collagen is a marker for hypertrophic stage of late chondrocyte 
differentiation, which occurs physiologically during endochondral ossification.  
In native tissue, chondrocytes maintain their spherical morphology and have the 
ability to produce cartilage-specific extracellular matrix (ECM), such as Aggrecan, 
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type II collagen and type I collagen. When cultured in monolayer as in a two 
dimensional substratum, chondrocytes tend to dedifferentiate into ellipsoidal shaped 
fibroblast-like cells and lose their ability to produce ECM. During this process the 
expression of type I collagen increases and the expression of type II collagen and 
aggrecan decreases. [15] 
With extended passaging, dedifferentiated chondrocytes lose the ability to form 
cartilaginous tissue and the cells now tend to form fibro-cartilaginous tissue 
biomechanically inferior to the original hyaline cartilage (Schnabel et al., 2002) [16]. 
The pathways underlying dedifferentiation are not completely understood and 
characterized and can involve regression to any earlier developmental state, 
progression into a post differentiated senescent hypertrophic or pathological state, or 
conversion into a maintenance state that lacks features of the differentiated state. 
Attempts have been made lately to determine the pattern of gene expression that 
distinguishes differentiated articular chondrocytes from other types of chondrocytes, 
such as dedifferentiated cells and was shown in a study by Cheng T. et al., 2011. [17] 
These facts led to a forced search for a different treatment approach of cartilage 
defects. During the last years, clinical approaches have been various, including 
microfracture, osteochondral allograft transplantation, autologous cartilage 
transplantation (ACT), autologous chondrocyte implantation (ACI), and many others. 
Autologous chondrocyte implantation has first been used clinically in the 1990s, after 
successful in vivo testing in rabbits. [18]. These first encouraging results led to the 
development of two fields of research in tissue engineering. The first field of tissue 
engineering research aims to improve the ACI technique by selecting the adequate 
autologous chondrogenic cells, the second field aims to develop three-dimensional 
matrices, capable of supporting the growth of phenotypically stable chondrocytes.  
Various studies have incorporated biological signals into scaffolds and have 
evaluated their effects on cell behavior such as proliferation, ECM production, 
spreading and adhesion. The effects of the cell adhesion peptide RGD (arginine-
glycine-aspartate)  have been extensively studied for example by Mann et al. [19] 
Rowley et al. [20] and many others [21-23] As well as the effects of integrins which 
are heterodimeric cell surface receptors, mediate adhesion between chondrocytes 
and the ECM, by binding to ligands with an exposed RGD (Arg-Gly-Asp) sequence. 
These receptors stimulate intracellular signaling and gene expression involved in cell 
growth, migration, and survival. The same process, were found to lead to thrombosis, 
  7 
 
inflammation, and cancer if not properly regulated. Because of this, research has 
focused on developing RGD peptides that would mimic cell adhesion proteins and 
bind to the cell surface receptors. 
Research groups around the world compose hydrogels of different type of polymers, 
add biofactors, such as growth factors or even viruses, apply loading, all aiming to 
optimize the physical properties of the scaffolds.  
Naturally derived polymers, such as alginate, agarose, chitosan, collagen - including 
collagen type I/II, fibrin and hyaluronan have been shown to be attractive 
biomaterials because of their biochemical similarity to cartilage. [24] 
Collagen hydrogels promote cartilage formation by encapsulated chondrocytes. The 
cells interact with collagen gels via integrins, which can remodel collagen through the 
secretion of collagenase. [25] Hydrogels composed of collagen type II on the other 
hand, have been shown to promote efficient chondrogenic differentiation of 
embedded mesenchymal cells. [26] Currently the groups around Hao et al. and 
Hoemann et al. investigate the capability of cartilage defects repair in vivo, with 
chondrocytes encapsulated in injectable chitosan hydrogels and hydrogels based on 
chitosan and glycerol phosphate in phase II clinical trials. [27] [28] 
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3. Material and methods 
 
3.1. Cartilage sampling 
 
Full thickness bovine articular cartilage samples were obtained from the femoral head 
and the patellar surface from 6 Brown Swiss or Red Holstein cattle within 12hours 
post-mortem. The samples derived from cows of about 2 years of age. We had no 
information about a clinical history of arthritis or other pathology affecting cartilage, 
but in all samples there were lesions found on the cartilage surface, such as signs of 
fibrillation and change in color. All samples therefore were collected from areas which 
appeared normal by morphological examination.  
The cartilage samples were immediately further processed, with the exception of the 
samples of native cartilage for PCR, which were kept in culture medium and were 
immediately frozen. 
 
3.2. Preparation of media 
 
3.2.1 Isolation Medium 
 
Sterile DMEM-F-12, 50µg/ml gentamicin, 360 µg/ml L-glutamine 
 
3.2.2 Culture medium 
 
Sterile DMEM-F-12, 50µg/ml gentamicin, 360 µg/ml (2.5mM) L-glutamine, usually 
with 10% FBS or serum-free culture medium as indicated in the text.  
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3.3 Chondrocytes isolation 
 
Cartilage was sequentially digested with 0.2% pronase and 2x collagenase P 
according to a previously described procedure. [29] 
Briefly, isolation medium was pre-warmed to 37°C and then the total amount of 
Pronase enzyme needed was added. The cartilage then was dissolved for 60 
minutes in a 37°C, 5% CO2 tissue culture incubator. After Pronase digestion, the 
pronase was removed and the cell suspension was washed 3 times, 2 minutes each, 
with isolation medium. Then the suspension was filtered through a 0.22µm sterile 
Millipore filter. 
The digestion was then continued by adding previously warmed collagenase P in 
isolation medium (final concentration is 0.0025%) and again dissolved for 60 minutes 
at 37°C. The resulting cell suspension was filtered through a 0.22µm sterile Millipore 
filter and then centrifuged at 1100 rpm for 15 minutes at 4°C. After a first 
centrifugation, the cells were washed in isolation medium and again centrifuged for 
another 3 times. After the last centrifugation, the chondrocytes were resuspended in 
10ml isolation medium, counted, and either seeded in tissue culture flasks and 
cultured or frozen for later use.  
 
 
3.4 Monolayer Culture 
 
Chondrocytes were seeded in tissue culture flasks for cell expansion at a 
concentration of 2.5 x 106 cells per 150cm2 flasks with a total volume of 20ml/flask. 
Media was changed every other day until the cells reached confluence after about 
1.5 weeks. At confluence cells were harvested by incubation with trypsin for 1 minute. 
Trypsin activity was neutralized by rinsing the cells with culture medium two times. 
The suspension then was centrifuged at 800 rpm for 5 minutes at 20°C. After the first 
centrifugation, the pellet was resuspended in 10ml culture medium and again 
centrifuged at 1400 rpm for 4 minutes. After this process the cells were either 
cultured for 7days and later frozen for gene expression or induced in hydrogels. 
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3.5 PEG hydrogel preparation  
 
PEG hydrogels were formed as described earlier by Lutolf et al., Ehrbar et al. [30, 31] 
and Bryant et al. [32]. Hydrogel networks were formed by factor XIIIa crosslinking of 
n-PEG-Gln with n-PEG-MMP-Lys. The cross-linking reaction was performed in Tris-
Buffer (TBS, 50mM, pH 7.6) containing 50mM calcium chloride and 10U/mL 
thrombin-activated factor XIIIa. For the formation of hydrogel disks, drops of yet liquid 
reaction mixture (20–40 mL) were sandwiched between sterile hydrophobic glass 
microscopy slides (obtained by treatment with SigmaCote, Sigma) separated by 
spacers of about 1mm thickness  and clamped with binder clips. Prior to gelation, the 
drop of reaction mixture contacting only hydrophobic surfaces spread spontaneously 
to form a disc.  
Hydrogels prepared at different precursor concentrations were formed by diluting 
concentrated 8-PEG-Gln/8-PEG-MMP-Lys precursor stock solutions (for 10% w/v 
gels) in order to minimize weighing error. Although gelation occurred within a few 
minutes at 37°C in a humidified incubator, the cross-linking reaction was allowed to 
proceed for about 1 h to ensure complete cross-linking.  
A spare volume of the total reaction volume was used for the potential incorporation 
of the cell adhesion peptide RGD (Arg-Gly-Asp). A change in the crosslinking density 
of PEG hydrogels can be achieved by in-/ or decreasing the concentration of the 
PEG solutions, or by using branched PEG structures. [32-34]. A total of six different 
gel conditions were prepared. The conditions were: +RGD, - RGD, Col I, 1.5%, 2.5% 
and 3.5% crosslinking gel density.   
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3.6 Analysis of cell viability 
 
To visualize the encapsulated chondrocytes in the hydrogels, a fluorescent 
membrane integrity assay, LIVE/DEAD® Assay (Invitrogen) was employed. All six 
different conditions were analyzed on day 0, 3, 7, 13, 17, 21 and day 38.  
The 3D gels were cut in half so one part could be analyzed whereas the other half 
was further kept in medium for direct comparison of the same gel at different time 
points.  
 
The hydrogels were rinsed with PBS for a few seconds, and 1ml of culture medium 
was added after the removal of the PBS. Then the constructs were stained with 1µl of 
4mM calcein acetoxymethyl (Fluka) and 1µl of 2mM ethidium homodimer-1 (Fluka) 
and incubated for 10 minutes at 37°C.  
After the incubation, the medium containing the dyes was removed and fresh culture 
medium was added. The samples then were imaged by fluorescence microscopy, 
using a Zeiss Axiovert 200M.  
 
 
3.7 Gene expression analysis 
 
Total RNA was isolated from three hydrogel constructs (1.5%, 2.5%, 3.5%) and from 
2D cell pellet from day 7 as well as fresh cartilage as a control. RNA extraction was 
performed with RNeasy Minikit following the details in the manufacturer’s protocol 
(Qiagen, Valencia, CA). 
The cDNA was synthesized by reverse transcription (RT) with Superscript First 
Strand Synthesis System (Invitrogen, Carlsbad, CA). Then quantitative RT-PCR was 
performed by combining the cDNA solution with reagents from a Taq PCR Master 
Mix kit (Qiagen, Valencia, CA), as well as oligonucleotide primers and probes that 
were created for the genes of interest (Sox9, Agg, type II collagen, and type I 
collagen) and the housekeeping gene control (GAPDH and 18S).   
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3.8 Histology 
 
Three hydrogels (1.5%, 2.5%, 3.5% no RGD) were harvested for histological 
evaluation at day 35. The samples were fixed overnight in 4% paraformaldehyde at 
4°C and then transferred to 70% ethanol until embedded in paraffin and then cut in   
4 - 5µm thick sections, according to standard histological techniques.   
The sections were then deparaffinized, rehydrated and stained with Fast green and 
safranin-T as well as Masson’s Trichrome to assess cell morphology, collagen fibers, 
glycosaminoglycans (GAG) and proteoglycan (PG) synthesis. 
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4. Results 
 
4.1 Cell viability 
 
Prior to seeding, a good cell viability (>95%) was assessed, by Trypan blue 
exclusion. The cell viability, as evaluated by Live/Dead double staining (Fig.2), varied 
significantly depending upon the ECM environment of the seeded chondrocytes. 
Generally, the manipulation of the cells during the seeding process seemed to have a 
negative effect upon their viability, which was reflected in an initial decrease of the 
cell viability.  A few days after seeding the number of viable cells increased again in 
all six conditions. 
Cell viability within the +RGD, -RGD and Col I constructs initially significantly 
decreased between day 0 and 3, but steadily increased thereafter. In the other 
hydrogels the de/- and increase of viable cells could not have been observed as 
much.  
The six different conditions were then compared to each other at 3 periods of time. 
The table (Fig. 1) further describes the observations that were made.  
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Fig. 1 
 
Conditions days 3-7 days 17-21 day 38 
+RGD 
 ~40% dead cells 
 Cells showed a rounded 
morphology  
 little ECM produced 
 cell number increased 
 Cells showed a rounded 
morphology  
 ECM increased 
 Very few dead cells 
 Cells showed a rounded 
morphology  
 ECM increased 
-RGD 
 ~40% dead cells 
 Cells showed a rounded 
morphology  
 Little but more ECM 
produced compared to 
+RGD 
 Cell number increased  
 Cells showed a rounded 
morphology  
 Small clusters of 3-5 
cells were formed 
 Very few dead cells 
 Cells showed a rounded 
morphology  
 Cells are uniformly 
spread 
1.5% 
 Only a few dead cells 
 Cells showed a rounded 
morphology  
 Much ECM produced 
 Only a few dead cells 
 Cells showed a 
fibroblastic morphology 
 ECM increased 
 Very few dead cells 
 Cells are clustered in 
larger islands 
 ECM increased 
2.5% 
 Only a few dead cells 
 Cells showed a rounded 
morphology  
 Much ECM produced 
 Very few dead cells 
 Small cell clusters  
 Cells showed a 
fibroblastic morphology 
 ECM increased, 
seemingly areas with 
more and some with 
less ECM (Lacunae) 
  
 No dead cells found 
 Cells separated, no cell 
clusters  
 Cells showed a rounded 
morphology again,  no 
fibroblastic appearance  
3.5% 
 More dead cells 
compared to 1.5% and 
2.5% gels 
 Cells showed a rounded 
morphology  
 Only a few dead cells 
 Small cell clusters  
 Cells showed a 
fibroblastic morphology 
 ECM increased 
 Only a few dead cells 
 Cells showed a rounded 
morphology,  little 
fibroblastic appearance 
 ECM increased, 
seemingly areas with 
more and some with 
less ECM (Lacunae) 
 
Col I 
 ~50% dead cells 
 Cells showed a rounded 
morphology  
 little ECM produced 
 ~10% dead cells 
 Cells showed a rounded 
morphology  
 ECM increased 
 Very few dead cells 
 Cells showed a rounded 
morphology  
 ECM increased 
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Fig. 2 Zeiss Axiovert 200M 10x magnification 
 
  
-RGD   day 7      -RGD   day 38   
 
 
  
 
 
 
 
 
 
+ RGD day 7     + RGD  day 38 
 
     
 
 
 
 
 
 
 
 
1.5%  day 7     1.5%  day 38 
 
 
 
 
  16 
 
 
 
 
 
 
 
 
 
2.5%  day 7     2.5%  day 38 
 
 
 
 
 
 
 
 
 
3.5%  day 7     3.5%  day 38 
 
 
 
 
 
 
 
 
 
 
Col I  day 7     Col I  day 38 
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4.2 Gene expression analysis 
 
To elucidate the effects of the different gel densities (1.5%, 2.5%, 3.5%) on gene 
expression, aggrecan, collagen type I, collagen type II as well as Sox9 expressions 
by chondrocytes encapsulated in the hydrogels, were normalized to the expression 
levels for native articular cartilage.  
Collagen type I which is the most abundant collagen in the human body is believed to 
be expressed in dedifferentiated chondrocytes, whereas Sox9 is a key transcription 
factor associated with chondrocyte differentiation. Aggrecan which provides the 
osmotic properties necessary to resist compressive load, plays an important role in 
mediating chondrocyte-chondrocyte and chondrocyte-matrix interactions through its 
ability to bind Hyaluronan. [35, 36] 
As shown in Figure 3, 4 & 5, the relative gene expression level of collagen type I 
increased in all conditions with the increase of culture time and it shows its maximum 
in the hydrogel with 3.5% density. Instead, the relative gene expression level of 
collagen type II decreased. Aggrecan first was up-regulated and then down-regulated 
in week 5. However, Sox9 shows a constant increase in the 1.5% and 2.5% density 
gels and a decrease after an initial increase in week 1 in the 3.5% gel.  
These results indicate that the dedifferentiation was enhanced by the increase of the 
culture time and density. 
However, the hydrogel with 1.5% density showed the best Collagen typ I/Collagen 
type II/Sox9 ratio as for non-dedifferentiated chondrocytes.  
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Fig. 3 Gene expression week 1    Fig. 4 Gene expression week 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5 
Gene expression week 5, 
Normalized Fold Expression to 50 
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4.3 Histology 
 
The histological evaluation confirmed the presence of a cartilage like tissue maturing 
within the hydrogels.  
Figure 6 shows the staining of histological sections of 1.5%, 2.5% and 3.5% density 
hydrogels with Safranin-T/fast green for proteoglycans which are stained red and 
Masson’s trichrome method for collagen which is stained blue, after 35 days of in 
vitro culture. Both, Safranin-T/fast Green and Masson’s trichrome stained sections 
showed that the cells were evenly dispersed throughout the hydrogel beads.  
However, on the whole, the findings of the histological evaluation confirm the findings 
of the Live/dead assay. Generally the cells on the surface of the hydrogel constructs 
are smaller and less rounded than those in the interior. Overall, the cells in the 1.5% 
hydrogels showed less rounded and more fibroblastic morphology than the cells 
within the 2.5% and 3.5% hydrogels and the chondrocytes showed an elongated 
shape without lacunae. Also the more dedifferentiated appearing cells of the 1.5% 
gels formed a tissue with less Safranin-T/fast Green and Masson’s trichrome 
staining. On the other hand the staining of the 2.5% and 3.5% gels indicate a high 
content of proteoglycans and collagen as confirmed earlier by gene expression. 
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Fig. 6 
 
 1.5% Safranin-T/ 
fast green 
 
 
 
 
 
 
1.5% Masson‘s 
trichrome 
 
 
 
 
 
           
2.5% Safranin-T/ 
fast green 
 
 
 
 
 
 
2.5% Masson’s 
trichrome 
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3.5% Safranin-T/ 
fast green 
 
 
 
 
 
 
3.5% Masson’s 
trichrome 
 
 
 
 
 
 
 
  
  22 
 
5. Discussion 
 
The goal of cartilage tissue engineering is to construct an implantable material with 
the aim to restore the original function by the regeneration of a fully differentiated 
tissue which has the same physiological properties as the healthy donor tissue. 
Although autologous chondrocytes implantation and second generation techniques 
based on the use of biocompatible and bioresorbable scaffolds preseeded with 
autologous chondrocytes have been widely applied in clinical practice for years, the 
results are far from being satisfactory as for a long-term therapy. In cartilage tissue 
engineering, the main problems are the production of a histological hyaline-like 
material, which can be fixed in the receiving site and provide mechanical stiffness 
without limiting the physiological function of a joint. The design of a 3D scaffold with 
the aim to induce and maintain cell differentiation, produce extracellular matrix (ECM) 
and ensure cell survival, requires an understanding of cell response in vivo and in 
vitro. It was shown that chondrocytes interact with their surrounding environment to 
receive biochemical cues from their ECM and PCM (pericellular matrix). [37] In 1993, 
Adams and Watt et al. showed that these interactions are essential in the regulation 
of tissue development and maintenance. Other studies investigating the 
chondrogenic differentiation of mesenchymal stem cells therefore suggest that 
fibronectin or its adhesive component, RGD are such needed cues to induce cell 
differentiation. [38] 
The study presented here investigated the role of RGD and different densities in PEG 
hydrogels on chondrogenic differentiation. We chose the bovine model because of 
the accessibility of bovine tissue and because relatively large amounts of tissue can 
be obtained per joint. Also, bovine cartilage has been thoroughly investigated over 
the past years.   
The cell viability as observed in the Live/Dead assay was good in all six constructs. In 
the overall comparison the gels without RGD and without Col I, showed significantly 
higher cell numbers, as well as viable cells, than gels containing RGD. The analysis 
of the six different gel conditions showed that the cells within gels with a density of 
2.5% and 3.5% seemed to have the most alike morphology as compared to native 
cartilage and showed no or only little signs of dedifferentiation.  
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However, different research groups showed good results using collagen I gels 
containing autologous MSCs (mesenchymal stem cells) for in vivo studies on sheep 
[39] and in humans, where they have been transplanted into cartilage defects. [40] 
In our study the constructs containing RGD did not stimulate cartilage repair 
sufficiently as shown in Live/Dead assay. Our findings confirm the results of previous 
studies made, which found no positive effects of RGD without the application of 
dynamic loading. [21, 41] Therefore, since the presence of RGD did not show the 
expected positive effects on chondrocyte proliferation, we decided to focus on the 
influence of different gel densities.  
The findings of the Live/Dead assay were confirmed with histological analysis, which 
showed a more fibroblastic morphology of the cells within 1.5% hydrogels, compared 
to gels with higher (2.5% and 3.5%) densities. Also cells within hydrogels with a 
higher density seemed to produce more ECM compared to the gel with the lower 
1.5% density, since a more intense Masson’s trichrome and Safranin-T/fast Green 
staining could be observed.  
Interestingly the comparison of gene expression analysis of the three different density 
conditions showed a better Agg, Sox9, Col2 to Col1 gene ratio in means of more 
differentiated chondrocytes in 1.5% density gels. Also, Sox9 was only constantly up 
regulated in the 1.5% gels, whereas it was only slightly up regulated in 2.5% and 
down regulated in 3.5% gels. These findings disagree with the observation of a more 
fibroblastic morphology and therefore more dedifferentiated appearance of the cells 
in Live/Dead assay and histological evaluation. This could mean that the 
differentiation process takes longer in lower density gels, but may result in a better 
gene distribution, compared to native cartilage. On the other hand, higher ECM 
production as seen in 2.5% and 3.5% hydrogels indicate a higher and faster cell 
proliferation. 
Our findings are supported by previous findings of Bryant and Anseth et al. [34] 
where they described that chondrocytes produce more ECM components when they 
are encapsulated in PEG hydrogels with lower crosslinking densities and higher 
swelling ratios. These results were also confirmed by two groups working with MSCs 
instead of chondrocytes. [42, 43] Nicodemus et al. conclude that less crosslinked 
hydrogels may lead to the formation of a thicker pericellular matrix, since the ECM 
components may immediately surround the cells, which affects cell-matrix 
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interactions. [43] Kisiday et al. even concluded that in the absence of load, 
crosslinking density appears to be the dominant parameter that determines cartilage 
formation, because it regulates the diffusion of the ECM components. [44] 
All these findings may be of interest for further investigation of the effect of different 
gel densities on chondrocyte proliferation. Longer culture times may be needed to 
detect changes in cellular response due to the change of the gel density as well as 
the addition of RGD, but in the presence of dynamic loading. 
Overall we find it necessary to compare different conditions on different time points to 
the original donor cartilage by gene expression analysis. Only the direct comparison 
to native tissue allows an analysis of the differentiation process of the chondrocytes 
within the hydrogels. Histological staining as well as Live/Dead assay alone seems to 
leave too much room for personal interpretation. The use of histomorphometry, 
facilitating the comparison between stained sections, should be considered, which 
would help to compare the results more effectively.  
Since chondrocyte behavior is controlled by multiple coefficients, combining different 
factors that have been found to be positively influencing chondrocyte behavior like 
dynamic loading, scaffold material, seeding density and growth factors, seems to be 
essential.  
As shown by various research groups [45-47], the mechanical properties of cartilage 
depend on donor species and age and can vary widely. It was found, that immature 
chondrocytes tend to proliferate more and produce more ECM and show greater 
response to the application of growth factors, compared to mature chondrocytes. [48-
50].  
Therefor a potential limitation of our study may be due to different problems in 
context of harvesting of the cartilage material. In almost all donor animals, despite 
their age of approximately only two years, osteoarthritis (OA) could be found. As it 
was observed more often in knee joints than in hip joints, we would recommend 
harvesting native cartilage samples from hip joints, since the perimeter of the OA 
can’t be determined macroscopically and an influence on the surrounding ECM and 
collagen constructs can’t be excluded. Also the deepness of the cartilage collection 
regarding the total cartilage thickness at the harvesting sites should not be ignored, 
as different cell types could be found, due to enchondral differentiation.  [51] 
Although the exact mechanism of different hydrogel densities and the influence of 
RGD are still to be elucidated, this study demonstrates important findings of how 
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much small changes of the cell surrounding crosslinking density can change 
chondrocyte phenotype and ECM synthesis. Overall, our findings further support 
earlier observations and evidence in the literature, that the incorporation of RGD, 
without the presence of dynamic loading, does not show a positive effect on cell 
matrix interactions.  
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6. Summary and future research aspects  
 
Current research has focused on creating three-dimensional (3D) scaffolds from 
biocompatible and biodegradable materials, which provide a structure and 
mechanical support for the cells seeded within the constructs, allowing them to 
ultimately growing into a functional tissue engineered construct.  
Hydrogels have been demonstrated as suitable for creating scaffolds and they are 
well known for their biocompatibility. Recently, layered constructs were shown to be 
able to reduce strain discontinuities between the fabricated scaffolds and the 
surrounding natural cartilage. Thus, engineering functional cartilage out of artificial 
scaffolds with matching mechanical properties has proven to be extremely difficult 
and to make things even more challenging, the mechanical properties of the 
constructs change dynamically with time as the tissue regenerates and the scaffold 
degrades. Therefore, engineered cartilage so far shows to be mechanically inferior to 
native cartilage.  
Although some research groups began to investigate the engineering of zonally 
organized cartilage, using different chondrocytes harvested from different zones of 
cartilage and encapsulating them in layered hydrogels [52, 53], there is still more 
understanding needed of how to construct cartilage with appropriately organized 
ECM. We also need to more investigate the degradation properties of the used 
scaffolds, such as hydrogels, because they determine the physical and structural 
properties of the scaffolds. Kloxin et al. therefor used a photodegradable nitro-benzyl-
derived moiety, which they incorporated into PEG based hydrogels, making the 
degradation process visible by the application of light [41]. Little et al. [54] suggest to 
first develop a mechanical model, such as mathematical modeling, that may provide 
an alternative to mechanical testing. Another advantage of mathematical models is 
that it can be used to derive or estimate the mechanical properties of individual 
material phases within the cartilage. Different groups used the commercial software 
ABAQUS to model cartilage tissue behavior under compression. [55, 56]  
Other popular approaches are methods and techniques to enhance the mechanical 
properties, by controlling the amount of ECM such as PG and collagen produced.  
Hansen et al. and Waldman et al. showed that collagen and PG levels within the 
ECM can be controlled with hydrostatic pressure and dynamic shear or compression. 
[57, 58] Hansen et al. showed that a loading frequency of 1Hz is optimal for ECM 
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production, whereas the ECM production can be inhibited with low (0.3Hz) or high 
(3Hz) frequencies. It also has been shown that the compression amplitude can 
regulate collagen and PG synthesis. [59]  
These and similar findings have been recently applied to bioreactor design, with the 
aim to mimic the dynamic forces seen in the native joints and thereby create cartilage 
with similar mechanical properties. [60, 61] 
Commonly fetal bovine serum (FBS) is added to cell culture, since it is known to 
increases cell proliferation and ECM production [62] Recent studies now have used 
different individual stimulants, such as bone morphogenetic proteins (BMP) or 
transforming growth factors, which compared to FBS have more defined composition 
and therefor give more repeatable results. [63-65]  
Also, more studies are required, investigating the effectiveness of chondrocyte 
sources. It is important that future studies concentrate on cells from clinically relevant 
sources, that don´t cause considerable damage to the donor site. Therefor MSCs are 
a valuable chondrocyte cell source because of ease with which they can be isolated 
and their various differentiation capabilities, but nevertheless that cell type still needs 
further investigation, since researcher are faced with challenging problems using 
MSCs in in vivo studies [66, 67]. However, an interesting finding about MSCs, which 
may be useful for clinical trials, is that it could been shown, that MSCs derived from 
skeletally mature horses produced superior cartilage tissue compared to age-
matched chondrocytes in peptide hydrogels. In addition, it was also shown that MSCs 
proliferated in the presence of TGFβ1, whereas the mature chondrocytes did not [48]. 
Therefor the hydrogels used in studies using MSCs should release growth factors 
such as TGFβ1, since they can reduce the in vitro cultivation time before 
implantation. Interesting newer studies tried to combine a slowly degrading scaffold 
material with high bulk stiffness, such as PCL (poly ε-caprolactone) and TGFβ3 
physically complexed with CS (chondroitin sulfate). They designed an interconnected 
pore network which lasts for at least 6 months, what allows the neo-cartilage formed 
from MSCs, to have sufficient time to mature without biomechanical overload. [68-70] 
Further research with the goal of in vivo application must also address immunological 
issues, such as the integration of host and stem cell based constructs and their 
interaction with the surrounding tissue, its age, disease and physical activity.  
Therefore, interdisciplinary studies are crucial to develop cartilage tissue 
engineering´s full potential in cartilage repair.  
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8. List of used abbreviations 
 
PEG  poly(ethylene glycol) 
PBS  Phosphate buffered saline 
ECM  extracellular matrix 
PCM  pericellular matrix 
HA  Hyaluronic acid  
LP  link protein 
AGC  Aggrecan  
sGAG  sulfated Glykosaminoglycane 
CS  Chondroitinsulfate 
PS  polystyrene 
RT-PCR real time polymerase chain reaction 
COL2  collagen type II  
COL1  collagen type I 
SZP  superficial zone protein 
SOX9  SRY (sex determining region Y)-box 9 
CLU  clusterin 
MIA  melanoma inhibitory activity 
COMP cartilage oligomeric matrix protein 
 
 
 
 
 
 
 
 
 
